Mirum Pharmaceuticals, Inc.

NasdaqGM:MIRM Voorraadrapport

Marktkapitalisatie: US$1.9b

Mirum Pharmaceuticals Eigendom

Wie zijn de grootste aandeelhouders en hebben insiders gekocht of verkocht?


Recente transacties met voorkennis

NasdaqGM:MIRM Recente transacties met voorkennis door bedrijven of personen
DatumWaardeNaamEntiteitRolAandelenMaximale prijs
18 Sep 24BuyUS$4,301Frazier Life Sciences Management, LPCompany115US$37.40
06 Sep 24BuyUS$9,563Frazier Life Sciences Management, LPCompany230US$41.58
27 Mar 24BuyUS$49,600Eric BjerkholtIndividual2,000US$24.80
25 Mar 24SellUS$111,017Peter RadovichIndividual4,303US$25.80
18 Mar 24BuyUS$51,600Eric BjerkholtIndividual2,000US$25.80
02 Feb 24SellUS$157,491Christopher PeetzIndividual6,013US$26.19
02 Feb 24SellUS$31,797Pamela VigIndividual1,214US$26.19
02 Feb 24SellUS$46,883Peter RadovichIndividual1,790US$26.19
02 Feb 24SellUS$22,184Lara LongpreIndividual847US$26.19
08 Jan 24SellUS$146,033Christopher PeetzIndividual5,209US$28.03
08 Jan 24SellUS$39,472Pamela VigIndividual1,408US$28.03
08 Jan 24SellUS$39,473Peter RadovichIndividual1,408US$28.03
08 Jan 24SellUS$28,568Lara LongpreIndividual1,019US$28.04

Volume handel met voorkennis

Insider-aankopen: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Opsplitsing eigendom

Wat is de eigendomsstructuur van MIRM?
Type eigenaarAantal AandelenEigendomspercentage
Individuele insiders832.2461,48%
Hedgefondsen4.370.0247,77%
VC/PE-bedrijven6.495.50711,5%
Instellingen44.566.44279,2%

Verwatering van aandelen: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.


Topaandeelhouders

Top 25 aandeelhouders bezitten 92.86% van het bedrijf
EigendomNaamAandelenHuidige waardeVerandering %Portefeuille %
13,6%
Frazier Life Sciences Management, LP
6.495.507US$262.4m0%10,47%
10,5%
Janus Henderson Group plc
4.988.747US$201.5m80,3%0,08%
9,16%
BVF Partners L.P.
4.370.024US$176.5m0%4,34%
7,58%
Eventide Asset Management, LLC
3.614.820US$146.0m9,53%2,3%
7,06%
BlackRock, Inc.
3.368.157US$136.1m4,02%geen gegevens
5,13%
The Vanguard Group, Inc.
2.446.733US$98.8m10,6%geen gegevens
3,71%
Rock Springs Capital Management LP
1.772.038US$71.6m-4,55%2,05%
3,32%
Citadel Advisors LLC
1.585.624US$64.1m13,9%0,06%
3,14%
Novo Holdings A/S
1.500.000US$60.6m0%0,04%
3,14%
State Street Global Advisors, Inc.
1.496.217US$60.4m-47%geen gegevens
2,7%
Tang Capital Management, LLC
1.287.107US$52.0m8,42%4,3%
2,59%
Cadian Capital Management, LP
1.235.121US$49.9m-46,1%1,97%
2,51%
T. Rowe Price Group, Inc.
1.199.220US$48.4m-24,9%geen gegevens
1,97%
Franklin Resources, Inc.
938.881US$37.9m0%0,01%
1,9%
Geode Capital Management, LLC
907.180US$36.7m30,1%geen gegevens
1,83%
Pictet Asset Management Limited
875.113US$35.4m-8,45%0,02%
1,66%
Medical Strategy GmbH, Asset Management Arm
794.125US$32.1m-11,6%1,79%
1,55%
Polar Capital Holdings Plc
741.049US$29.9m18,6%0,11%
1,53%
Avidity Partners Management, L.P.
731.104US$29.5m-36%1,13%
1,52%
Goldman Sachs Group, Investment Banking and Securities Investments
726.645US$29.4m9,01%0,01%
1,47%
First Turn Management, LLC
703.398US$28.4m-26,6%4,25%
1,47%
ClearBridge Investments, LLC
699.933US$28.3m166%0,02%
1,42%
William Blair Investment Management, LLC
677.939US$27.4m8,08%0,03%
1,29%
Norges Bank Investment Management
614.905US$24.8m-15,5%geen gegevens
1,11%
Morgan Stanley, Investment Banking and Brokerage Investments
529.030US$21.4m53,7%geen gegevens